Red Blood Cell Distribution Width: A Risk Factor for Prognosis in Patients with Ischemic Cardiomyopathy after

Biyang Zhang1, Yinxiao Xu1, Xin Huang1

  • 1Department of Cardiology, Capital Medical University Affiliated Anzhen Hospital, Beijing 100089, China.

Insights

Higher red blood cell distribution width (RDW) is linked to increased major adverse cardiovascular events (MACE) in ischemic cardiomyopathy patients after percutaneous coronary intervention (PCI). This finding highlights RDW as a significant prognostic marker for these patients.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Interventional Cardiology

Background:

  • Red blood cell distribution width (RDW) is a known indicator of cardiovascular disease severity and prognosis.
  • Previous studies suggest a correlation between RDW and adverse cardiovascular outcomes.

Purpose of the Study:

  • To investigate the association between RDW and prognosis in ischemic cardiomyopathy (ICM) patients undergoing percutaneous coronary intervention (PCI).
  • To determine if RDW can predict major adverse cardiovascular events (MACE) in this patient population.

Main Methods:

  • Retrospective analysis of 1986 ICM patients who underwent PCI.
  • Patients stratified into three groups based on RDW tertiles.
  • Kaplan-Meier survival analysis, multivariate Cox regression, and restricted cubic spline (RCS) analysis were used to assess MACE and its components.

Main Results:

  • Higher RDW tertiles were significantly associated with increased incidence of MACE, all-cause mortality, and revascularization.
  • RDW independently predicted increased risks of MACE, all-cause mortality, and revascularization after adjusting for confounding variables.
  • Nonlinear association between RDW and MACE was observed; elderly patients and those with hypercholesterolemia or without anemia showed higher MACE risk with elevated RDW.

Conclusions:

  • RDW is a significant independent predictor of adverse cardiovascular outcomes in ICM patients undergoing PCI.
  • Elevated RDW levels are associated with a higher risk of MACE in this cohort, suggesting its utility as a prognostic biomarker.
Abstract